Pulmonary Fibrosis News

July 28, 2021July 28, 2021

Umbilical Cord Stem Cells Help Limit Inflammation in Mice

Stem cells found in human umbilical cords limited lung damage associated with pulmonary fibrosis (PF) by reducing an excessive inflammatory immune response, a recent study of mice has found. Understanding ... Read more

July 27, 2021July 27, 2021

US Patient Groups Give Thumbs-Up to Rule Against Surprise Billing

Pulmonary Fibrosis News

The National Organization for Rare Disorders (NORD) is applauding the Biden administration for announcing a rule to protect consumers from surprise medical billing, in a joint statement with 26 other ... Read more

July 27, 2021July 27, 2021

Switching Between Antifibrotics May Help IPF Patients Live Longer

Pulmonary Fibrosis News

Switching antifibrotic treatment is generally well-tolerated among people with idiopathic pulmonary fibroisis (IPF), and those who did generally lived several years longer than those who did not, a study from ... Read more

July 26, 2021July 26, 2021

PF Diagnosis, Care in UK Also Fell to COVID-19 Pandemic

COVID-19 News, Pulmonary Fibrosis News

More than 100,000 fewer hospital appointments were logged by people with lung diseases like idiopathic pulmonary fibrosis (IPF) in England between March 2020 and 2021, relative to the average annual ... Read more

July 23, 2021July 23, 2021

Partnership Aims to Lower Out-of-Pocket Costs for Rare Disease Meds

Pulmonary Fibrosis News

AllianceRx Walgreens Prime, a specialty and home delivery pharmacy, is partnering with TailorMed, a healthcare technology company, to help lower out-of-pocket prescription costs for specialty pharmacy patients. Medications attained through specialty pharmacies ... Read more

July 23, 2021July 23, 2021

Computerized Imaging Tool Helps ID New IPF Subtype

Pulmonary Fibrosis News

Idiopathic pulmonary fibrosis (IPF) co-occurring with a second lung disorder represents a distinct new IPF subtype with a poor prognosis and its own set of treatment considerations, a recent study ... Read more

July 21, 2021July 21, 2021

Specific Fibroblast Cells Prevent Fibrosis in PF Mouse Model Study

COVID-19 News, Pulmonary Fibrosis News

A subset of fibroblasts that produce a protein called meflin in lung tissues taken from people with idiopathic pulmonary fibrosis (IPF) was found to prevent fibrosis, or tissue scarring, in ... Read more

July 20, 2021July 20, 2021

Lungs ‘Primed’ for Severe COVID-19 in People With IPF, Like Disorders

COVID-19 News, Pulmonary Fibrosis News

Changes in gene activity and immune cell populations in the lungs of people with chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF), may predispose these patients to severe COVID-19, ... Read more

July 19, 2021July 19, 2021

Automated Imaging Method Seen to Accurately Capture PF Severity

COVID-19 News, Pulmonary Fibrosis News

A new, automated computer image analysis technique was able to accurately assess and measure the severity of pulmonary fibrosis (PF) using patients’ lung tissue samples, a study reported. According to ... Read more

July 16, 2021July 16, 2021

Grant Supports Miniprotein Binder as Potential IPF Therapy

COVID-19 News, Pulmonary Fibrosis News

The Washington Research Foundation (WRF) has awarded a $250,000 grant to support the development of a novel miniprotein binder to help treat idiopathic pulmonary fibrosis (IPF). The grant was awarded ... Read more

July 15, 2021July 15, 2021

Nominations Open for 2022 Eurordis Black Pearl Awards

Pulmonary Fibrosis News

Nominations are now open for the worldwide 2022 Black Pearl Awards from Eurordis-Rare Diseases Europe. The 12 award categories recognize individual advocates, policy makers, researchers, organizations, and companies who work ... Read more

July 14, 2021July 14, 2021

Enrollment Resumes in GALACTIC-1 Trial of Inhaled Therapy GB0139

Pulmonary Fibrosis News

Enrollment has resumed, under a revised trial protocol, in the Phase 2b study GALACTIC-1, which is evaluating Galecto’s investigational inhaled therapy GB0139 in adults with idiopathic pulmonary fibrosis (IPF). Galecto ... Read more

July 13, 2021July 13, 2021

NeRRe Raises £20M to Develop Orvepitant for IPF Chronic Cough

Pulmonary Fibrosis News

NeRRe Therapeutics has raised £20 million (nearly $28 million) to develop orvepitant as a treatment for the chronic cough that can impact quality of life for people with idiopathic pulmonary ... Read more

July 12, 2021July 12, 2021

Study to Test If Wearable Device Can Predict Symptom Worsening

Pulmonary Fibrosis News

Researchers at the University of Alberta are studying whether combining a commercially available wearable device with artificial intelligence can effectively predict symptom worsening in people with chronic lung conditions, such ... Read more

July 9, 2021July 9, 2021

PFF Summit Will Focus on Research, Quality of Life

Pulmonary Fibrosis News

With an emphasis on research and how well patients are living, the Pulmonary Fibrosis Foundation’s (PFF) PFF Summit 2021 is set to take place virtually Nov. 8–13. The global biennial ... Read more